Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types.

Loh KM, Chen A, Koh PW, Deng TZ, Sinha R, Tsai JM, Barkal AA, Shen KY, Jain R, Morganti RM, Shyh-Chang N, Fernhoff NB, George BM, Wernig G, Salomon REA, Chen Z, Vogel H, Epstein JA, Kundaje A, Talbot WS, Beachy PA, Ang LT, Weissman IL.

Cell. 2016 Jul 14;166(2):451-467. doi: 10.1016/j.cell.2016.06.011.

2.

New tools for studying microglia in the mouse and human CNS.

Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, Weissman IL, Chang EF, Li G, Grant GA, Hayden Gephart MG, Barres BA.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1738-46. doi: 10.1073/pnas.1525528113. Epub 2016 Feb 16.

3.

Upregulation of CD11A on hematopoietic stem cells denotes the loss of long-term reconstitution potential.

Fathman JW, Fernhoff NB, Seita J, Chao C, Scarfone VM, Weissman IL, Inlay MA.

Stem Cell Reports. 2014 Nov 11;3(5):707-15. doi: 10.1016/j.stemcr.2014.09.007. Epub 2014 Oct 16.

4.

Engineered SIRPĪ± variants as immunotherapeutic adjuvants to anticancer antibodies.

Weiskopf K, Ring AM, Ho CC, Volkmer JP, Levin AM, Volkmer AK, Ozkan E, Fernhoff NB, van de Rijn M, Weissman IL, Garcia KC.

Science. 2013 Jul 5;341(6141):88-91. doi: 10.1126/science.1238856. Epub 2013 May 30.

5.

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.

Tseng D, Volkmer JP, Willingham SB, Contreras-Trujillo H, Fathman JW, Fernhoff NB, Seita J, Inlay MA, Weiskopf K, Miyanishi M, Weissman IL.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11103-8. doi: 10.1073/pnas.1305569110. Epub 2013 May 20.

6.

Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification.

Inlay MA, Choe V, Bharathi S, Fernhoff NB, Baker JR Jr, Weissman IL, Choi SK.

Chem Commun (Camb). 2013 May 28;49(43):4971-3. doi: 10.1039/c3cc42179a.

7.

Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.

Fernhoff NB, Derbyshire ER, Underbakke ES, Marletta MA.

J Biol Chem. 2012 Dec 14;287(51):43053-62. doi: 10.1074/jbc.M112.393892. Epub 2012 Oct 23.

8.

Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation.

Smith BC, Fernhoff NB, Marletta MA.

Biochemistry. 2012 Feb 7;51(5):1028-40. doi: 10.1021/bi201818c. Epub 2012 Jan 24.

9.

A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase.

Fernhoff NB, Derbyshire ER, Marletta MA.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21602-7. doi: 10.1073/pnas.0911083106. Epub 2009 Dec 9.

10.

Nucleotide regulation of soluble guanylate cyclase substrate specificity.

Derbyshire ER, Fernhoff NB, Deng S, Marletta MA.

Biochemistry. 2009 Aug 11;48(31):7519-24. doi: 10.1021/bi900696x.

11.

Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells.

Mitchell DA, Morton SU, Fernhoff NB, Marletta MA.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11609-14. Epub 2007 Jul 2.

Supplemental Content

Loading ...
Support Center